Inhalation & Respiratory Drug Delivery USA Congress

  • Check with publisher
  • Published date: August 9, 2017
    • San Diego, California, United States

Oxford Global Conferences are proud to present our Inhalation & Respiratory Drug Delivery USA Congress, 12 – 13 March 2018, San Diego, USA with our co-located Formulation & Drug Delivery USA Congress. Across the two days, over 200 senior industry experts will present new trends in combination product design and the future directions of inhalation drug delivery research. Further discussion will focus on the challenges of bringing respiratory products to market and innovative aerosol science, including modelling and toxicology. Presentations will also feature key case studies on the latest trends in inhalation devices, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis.

Including 2 interactive streams:

• Development & Formulation of Inhaled Therapies
• Inhalation Devices & Analytics

Download Agenda:

Free Webinar Recording

Inhaled Insulin: Highway to Heaven or Road to Ruin?
Hosted by Jim Fink, Senior Fellow Clinical Aerosol Product Development, Dance Biopharm
Download for Free Today:

Stratification and Considerations for DPI Development
Hosted by Sven Stegemann, Professor, Graz University of Technology
Download for Free Today:

For further information regarding prices and possible discounts, please contact Guillaume Alonso on or call +44 (0)1865 248 455.

Result 0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Guidance on Software and Device Changes and the 510(k)

    Guidance on Software and Device Changes and the 510(k)

    Drug Development Fremont (California) August 14, 2017 Free

    Overview: The first guidance document clarifies key terms and provides insight as to how a risk assessment can help medical device manufacturers to evaluate whether a new 510(k) is required. Why should you Attend: Anyone who is involved in software a...

  • Batch Record Review and Product Release - 2017

    Batch Record Review and Product Release - 2017

    Drug Development Fremont (California) August 14, 2017 Free

    Overview: A strong batch record review system is essential in order to properly document all critical processing parameters that go along with the production and manufacture of pharmaceuticals, biologics, medical devices, etc. Why should you Attend: ...

  • N-hydroxysuccinimide ester 15 resin

    N-hydroxysuccinimide ester 15 resin

    Drug Development (United States ) June 6, 2017 Check with publisher

    The N-hydroxysuccinimide ester 15 resin is activated immunoaffinity supports that offer rapid, high efficiency coupling for all ligands with a primary amino group, including proteins throughout the entire range of pIs and low molecular weight compoun...